LGALS3 and Hyperglycemia: Subgroup analyses in our study supported these observations by demonstrating that both galectin-3 and sICAM-1 levels were highest in patients with poor glycemic control (HbA1c ≥ 6.45) and hyperglycemia (glucose ≥ 120 mg/dL).